Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
Phase IIA, multicenter, dose escalation study evaluating the safety and efficacy of weekly
S-8184 paclitaxel injectable emulsion in second line treatment of patients locally advanced,
metastatic, or recurrent transitional cell carcinoma of the urothelium.